Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions in a method of treating cancer. The dUTPase inhibitors disclosed contain a uracil isostere in the molecule represented by a 2,6-diketopiperazine moiety. Thioanalogs of the uracil isostere where a thione replaces each of the ketone are also disclosed.
本文提供了dUTP酶
抑制剂、包含此类化合物的组合物以及在治疗癌症的方法中使用此类化合物和组合物的方法。所公开的 dUTPase
抑制剂在分子中含有一个由 2,6-二酮
哌嗪基团代表的尿
嘧啶异位体。此外,还公开了以
硫酮取代各酮的尿
嘧啶异构体
硫代类似物。